SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-045049
Filing Date
2021-07-02
Accepted
2021-07-02 17:01:16
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4191
  Complete submission text file 0001209191-21-045049.txt   5785
Mailing Address 1042-B NORTH EL CAMINO REAL, SUITE 430 ENCINITAS CA 92024
Business Address
HALE DAVID F (Reporting) CIK: 0001024004 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50549 | Film No.: 211071139
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Issuer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations